UroGen Pharma Ltd. (URGN) Stock Analysis — Valuation, Growth & Financial Health

Five-Pillar Analysis for URGN

TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes UroGen Pharma Ltd. a strong or weak investment candidate.

▲ Valuation

Is URGN priced fairly?

P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and URGN's own history. Our valuation engine flags whether UroGen Pharma Ltd. is trading rich, fair, or cheap.

▲ Profitability

How efficient is UroGen Pharma Ltd.?

Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.

▲ Financial Health

Can URGN survive a downturn?

Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen UroGen Pharma Ltd.'s balance sheet for stress and flag liquidity or leverage risk.

▲ Returns

What's URGN earning on capital?

Return on Equity, Return on Invested Capital, and Return on Assets. We compare UroGen Pharma Ltd.'s capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.

▲ Growth

Is UroGen Pharma Ltd. expanding?

Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.

→ Get the Full Picture

See the complete URGN breakdown

Sign up free to unlock UroGen Pharma Ltd.'s full five-pillar analysis with live financial data, peer comparisons, and historical context.

Sign up free →

Frequently Asked Questions about URGN

Quick answers to the most common questions about UroGen Pharma Ltd..

What does UroGen Pharma Ltd. (URGN) do?

UroGen Pharma Ltd. is a publicly traded company under the ticker symbol URGN. Sign up to TopTier Strategy to view a full business overview — including segments, competitive position, and how revenue is generated.

How do I analyze URGN stock?

The five-pillar framework — Valuation, Profitability, Financial Health, Returns, and Growth — is the cleanest way to evaluate any stock, including URGN. Each pillar uses standardized metrics that let you compare UroGen Pharma Ltd. to its peers and to its own history.

Is URGN a good stock to buy?

Whether UroGen Pharma Ltd. fits your portfolio depends on your time horizon, risk tolerance, and investing style. TopTier Strategy gives you the structured data — valuation, profitability, balance sheet health, returns on capital, and growth — to make that decision with conviction.

Where can I see URGN's financial data?

Sign up free at TopTier Strategy to access UroGen Pharma Ltd.'s complete financial profile, including historical metrics, peer comparisons, and our five-pillar score breakdown.

Popular Stocks

Other widely-followed stocks investors research on TopTier Strategy.

UroGen Pharma Ltd. (URGN)